Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00993135 · ClinicalTrials.gov registry record
Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 10
- Enrollment target
NCT00993135: Completed study, sponsored by Vanderbilt University Medical Center.
NCT00993135 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00993135 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about how often kidney dysfunction occurs in children and young adults receiving methotrexate for acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment. PURPOSE: This research study is looking at kidney dysfunction in children and young adults who have received low-dose or intermediate-dose methotrexate for acute lymphoblastic leukemia.
Interventions
- OTHER medical chart review
- DRUG methotrexate
- PROCEDURE assessment of therapy complications
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2008-12 |
What the finished NCT00993135 record still lists
NCT00993135 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which medical chart review is the first listed.
NCT00993135 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00993135 about?
NCT00993135 is a clinical study titled "Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia". RATIONALE: Gathering information about how often kidney dysfunction occurs in children and young adults receiving methotrexate for acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment. PURPOSE: This research study is looking at kidney dysfunction in...
What is the current status of trial NCT00993135?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2008-12.
What interventions are being tested in trial NCT00993135?
The interventions under investigation include: medical chart review (OTHER), methotrexate (DRUG), assessment of therapy complications (PROCEDURE).
Who is sponsoring clinical trial NCT00993135?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia